Wellumio is a venture-backed medical device company on a mission to create universal access to diagnostic imaging.

Magnetic resonance is the gold standard modality in medical imaging due to its exceptional soft tissue contrast. However, its accessibility is limited by high costs and the need to transport patients to scanners. At Wellumio, we are driven by a simple yet transformative idea: instead of bringing patients to the scanner, we bring the scanner to the patients, wherever it is needed.

By providing point-of-care imaging, Wellumio enables healthcare professionals to deliver earlier diagnoses, faster treatments, and better outcomes. Our second-generation scanner, Axana, is 99% lighter than conventional MRI systems, making it the most portable head magnetic resonance imaging system in the global brain and neuroimaging market.

The company's first target application is acute stroke, a leading cause of human mortality and disability. Currently, only 1.5% ...